Retour aux marchés

Bourse de Tunis

Dernière mise à jour 29 sept. 2026
Ouvrir un compte d’investissement

Unite de Fabrication de Medicaments SA · UMED.TN

Tunisie · Santé · Pharmaceuticals · TND

Historique des prix

8.75 0%

Unite de Fabrication de Medicaments SA is a Tunisia-based company principally engaged in the pharmaceutical sector. The Company has labaroatories where it develops production in two main areas: Generic Drugs, where it concentrates on the production and marketing of drugs under its own brand of Unimed, and Shaped Drugs, which are the drugs manufactured for third party laboratories customers. The Company's product portfolio comprises Ophthalmology Otorhinolaryngologicals (OPHTA ORL) like Alzor, Atropine Unimed and Benzosept, among others; liquid injections, such as Bupicaine, Furoxem, Doperan and Ketomed, among others; powders for injections, such as Amoxil, Ampicil and Cefaxone, among others; Otorhinolaryngologicals (ORL) like Ofloxacine; and infusion solutions, such as Glucose 5% and Osmomed 5%, among others.

Connectez-vous pour débloquer l'historique complet des fondamentaux.

Se connecter
Indicateur  (TND, M) 2025 2024 2023 2022 2021
Chiffre d'affaires Total Revenue 160
EBITDA 59
EBIT 40.9
Résultat net Net Income 23.6
Marge nette Net margin 14.75%